Phosphodiesterase Inhibitors for Chronic Obstructive Pulmonary Disease: What Does the Future Hold? Maria Gabriella MateraPaola RoglianiMario Cazzola Current Opinion 10 October 2014 Pages: 1983 - 1992
Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies Kent ShihHendrik-Tobias ArkenauJeffrey R. Infante Leading Article Open access 25 October 2014 Pages: 1993 - 2013
New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities Paul P. DobeshJohn Fanikos Review Article Open access 10 October 2014 Pages: 2015 - 2032
Updated National and International Hypertension Guidelines: A Review of Current Recommendations Sverre KjeldsenRoss D. FeldmanBryan Williams Review Article Open access 15 October 2014 Pages: 2033 - 2051
Extended-Release Tacrolimus: A Review of Its Use in De Novo Kidney Transplantation Paul L. McCormack Adis Drug Evaluation 29 October 2014 Pages: 2053 - 2064
Riociguat: A Review of Its Use in Patients with Chronic Thromboembolic Pulmonary Hypertension or Pulmonary Arterial Hypertension Karly P. Garnock-Jones Adis Drug Evaluation 29 October 2014 Pages: 2065 - 2078
Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Review of Its Use in HIV Infection Emma D. Deeks Adis Drug Evaluation 29 October 2014 Pages: 2079 - 2095
Dulaglutide: First Global Approval Mark Sanford R&D Insight Report 04 November 2014 Pages: 2097 - 2103
